CIAM
VIR icon

Caitong International Asset Management’s Vir Biotechnology VIR Stock Holding History

Caitong International Asset Management’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$846 Sell
83
-5,058
-98% -$48.1K ﹤0.01% 1582
2026
Q1 		$46.1K Buy
5,141
+4,739
+1,179% +$37.8K 0.01% 814
2025
Q4 		$2.42K Sell
402
-287
-42% -$1.71K ﹤0.01% 1299
2025
Q3 		$3.93K Buy
689
+138
+25% +$706 ﹤0.01% 1277
2025
Q2 		$2.78K Buy
551
+433
+367% +$2.32K ﹤0.01% 1268
2025
Q1 		$765 Buy
+118
New +$1.05K ﹤0.01% 1649

Other funds holding VIR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GP
GSK plc London $602M AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Caitong International Asset Management's VIR Position: Q2 2026 in Review

Caitong International Asset Management reduced its Vir Biotechnology (VIR) stake by 98% in Q2 2026, selling an estimated $48.1K and leaving 83 shares worth $846. The position accounts for ﹤0.01% of the portfolio, ranked #1582.

Caitong International Asset Management first reported a position in VIR in Q1 2025 and has held it in 6 quarters since. The position peaked at $46.1K in Q1 2026. 237 funds tracked by Wall St. Rank hold VIR as of Q2 2026.

  • Caitong International Asset Management held 83 shares of Vir Biotechnology worth $846 as of Q2 2026.
  • Caitong International Asset Management sold 5,058 Vir Biotechnology shares in Q2 2026, an estimated $48.1K.
  • Vir Biotechnology made up ﹤0.01% of Caitong International Asset Management's portfolio in Q2 2026, its #1582 holding.
  • Caitong International Asset Management first reported a position in Vir Biotechnology in Q1 2025 and has held it in 6 quarters since.
  • Caitong International Asset Management's Vir Biotechnology position peaked at $46.1K in Q1 2026.
  • 237 funds tracked by Wall St. Rank held Vir Biotechnology as of Q2 2026.

Based on Caitong International Asset Management's 13F filing for Q2 2026, filed 5 Aug 2026.